Rare diseases
Investigational molecules
Locations
Back to France1 340 clinical trials in Lille, France across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study of tulisokibart compared to placebo in adults with moderate to severe Crohn's disease
FranceStudy of Ifinatamab Deruxtecan and Chemotherapy for Patients with Advanced or Metastatic Esophageal Squamous Cell Carcinoma
FranceLong-term safety study of tulisokibart in adults with Crohn's disease or ulcerative colitis
FranceStudy of IPH5201 and Durvalumab for Pre- and Post-Surgery Treatment in Patients with Early-Stage Non-Small Cell Lung Cancer
FranceStudy on the Effects of Pegozafermin for Patients with Nonalcoholic Steatohepatitis (NASH) and Fibrosis
FranceStudy on Anifrolumab for Adults with Polymyositis or Dermatomyositis
FranceStudy on the Safety of BHV-7000 for Adults with Hard-to-Treat Focal Onset Epilepsy
FranceStudy of Elafibranor for Adults with Primary Biliary Cholangitis
FranceStudy on Long-term Safety of Nivolumab and Drug Combination for Cancer Patients from Previous BMS Trials
FranceStudy on RVU120 and Venetoclax for Patients with Acute Myeloid Leukemia After Previous Treatment Failure
FranceStudy on the Long-term Safety and Efficacy of Pembrolizumab and Lenvatinib for Patients with Advanced Tumors
FranceStudy on Efruxifermin for Patients with Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) or Metabolic Dysfunction-Associated Steatohepatitis (MASH)
FranceThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking studies focusing on head and neck squamous cell carcinoma, exploring novel treatment combinations and targeted therapies. Additional research includes investigations into pancreatic cancer and gastric cancer treatments.
Studies are evaluating innovative therapeutic agents and their effectiveness in treating various forms of cancer.
Comprehensive research into Alzheimer's disease and Amyotrophic Lateral Sclerosis, examining new treatment approaches and disease mechanisms. Studies also include investigations of essential tremor treatments.
Research focuses on understanding disease progression and developing targeted interventions.
Innovative trials examining treatments for Crohn's disease and Multiple Sclerosis. Research includes novel approaches to managing chronic inflammatory conditions and immune system disorders.
Studies aim to improve treatment outcomes and develop more effective therapeutic options.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
